Muhammad Wasif Saif

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Saif Muhammad Wasif; Syrigos K I; Hotchkiss S; Shanley J; Grasso J; Ferencz T M; Syrigos K; Shah M M
Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer.
Shahrokni Armin; Rajebi Mohammad Reza; Saif Muhammad Wasif
Toxicity and efficacy of 5-fluorouracil and capecitabine in a patient with TYMS gene polymorphism: A challenge or a dilemma?
James Edward; Podoltsev Nikolai; Salehi Elahe; Curtis Brian R; Saif Muhammad Wasif
Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Muhammad Wasif Saif (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Saif Muhammad Wasif; Syrigos K I; Hotchkiss S; Shanley J; Grasso J; Ferencz T M; Syrigos K; Shah M M
Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer.
Cancer chemotherapy and pharmacology 2009;65(1):107-12.
2009: Shahrokni Armin; Rajebi Mohammad Reza; Saif Muhammad Wasif
Toxicity and efficacy of 5-fluorouracil and capecitabine in a patient with TYMS gene polymorphism: A challenge or a dilemma?
Clinical colorectal cancer 2009;8(4):231-4.
2009: James Edward; Podoltsev Nikolai; Salehi Elahe; Curtis Brian R; Saif Muhammad Wasif
Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect?
Clinical colorectal cancer 2009;8(4):220-4.
2009: Saif Muhammad Wasif; Shi Nianwen; Zelt Susan
Capecitabine treatment patterns in patients with gastroesophageal cancer in the United States.
World journal of gastroenterology : WJG 2009;15(35):4415-22.
2009: Saif Muhammad Wasif; Hashmi Sharukh; Bell Diana; Diasio Robert B
Prognostication of pancreatic adenocarcinoma by expression of thymidine phosphorylase/dihydropyrimidine dehydrogenase ratio and its correlation with survival.
Expert opinion on drug safety 2009;8(5):507-14.
2009: Saif Muhammad Wasif
Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer.
World journal of gastroenterology : WJG 2009;15(31):3855-64.
2009: Dimou Anastasios; Syrigos Kostas N; Saif Muhammad Wasif
Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis.
World journal of gastroenterology : WJG 2009;15(30):3734-43.
2009: James Edward; Waldron-Lynch Maeve G; Saif Muhammad Wasif
Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature.
Anti-cancer drugs 2009;20(7):634-8.
2009: Saif Muhammad Wasif; Oettle H; Vervenne W L; Thomas J P; Spitzer G; Visseren-Grul C; Enas N; Richards D A
Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas.
Cancer journal (Sudbury, Mass.) 2009;15(4):339-43.
2009: Strimpakos A S; Syrigos K N; Saif M W
Pharmacogenetics and biomarkers in colorectal cancer.
The pharmacogenomics journal 2009;9(3):147-60.
2009: Saif Muhammad Wasif; Peccerillo J; Potter Von
Successful re-challenge with panitumumab in patients who developed hypersensitivity reactions to cetuximab: report of three cases and review of literature.
Cancer chemotherapy and pharmacology 2009;63(6):1017-22.
2009: Tsimboukis Sotirios; Merikas Irene; Karapanagiotou Eleni M; Saif Muhammad Wasif; Syrigos Kostas N
Erlotinib-induced skin rash in patients with non-small-cell lung cancer: pathogenesis, clinical significance, and management.
Clinical lung cancer 2009;10(2):106-11.
2009: Saif Muhammad Wasif; Syrigos Kostas N; Katirtzoglou Nikos A
S-1: a promising new oral fluoropyrimidine derivative.
Expert opinion on investigational drugs 2009;18(3):335-48.
2009: Karapanagiotou Eleni M; Syrigos Kostas; Saif Muhammad Wasif
Heat shock protein inhibitors and vaccines as new agents in cancer treatment.
Expert opinion on investigational drugs 2009;18(2):161-74.
2009: Saif Muhammad Wasif; The Angeline; Ledbetter Leslie
Oxaliplatin-mediated autoimmune thrombocytopenia.
Clinical colorectal cancer 2009;8(1):61-2.
2009: Bustillo Ivan; Kaley Kristin; Saif Muhammad Wasif
Rash associated with the use of pegylated filgrastim in a patient with advanced pancreatic cancer.
Cutaneous and ocular toxicology 2009;28(4):181-4.
2009: Li Jia; Saif Muhammad Wasif
Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers.
Biologics : targets & therapy 2009;3():429-41.
2009: Bustillo Ivan; Larson Heidi; Saif Muhammad Wasif
Small intestine bacterial overgrowth: an underdiagnosed cause of diarrhea in patients with pancreatic cancer.
JOP : Journal of the pancreas 2009;10(5):576-8.
2009: Saadati Hamid; Peccerillo Jennifer; Kaley Kristin; Schilsky Michael L; Saif Muhammad Wasif
Gemcitabine-induced hepatitis in a pancreatic cancer patient receiving adjuvant therapy following metastasectomy.
JOP : Journal of the pancreas 2009;10(5):573-5.
2009: Saadati Hamid; Saif Muhammad Wasif
Oxaliplatin-induced hyperexcitability syndrome in a patient with pancreatic cancer.
JOP : Journal of the pancreas 2009;10(4):459-61.
2009: Saif Muhammad Wasif
Adjuvant treatment of pancreatic cancer in 2009: where are we? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
JOP : Journal of the pancreas 2009;10(4):373-7.
2009: Triano Laura R; Chang Bryan W; Saif Muhammad Wasif
New developments in the treatment of locally advanced pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
JOP : Journal of the pancreas 2009;10(4):366-72.
2009: Li Jia; Saif Muhammad Wasif
Any progress in the management of advanced pancreatic cancer? Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
JOP : Journal of the pancreas 2009;10(4):361-5.
2009: Strimpakos Alexios S; Syrigos Kostas N; Saif Muhammad Wasif
Pharmacogenetics in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
JOP : Journal of the pancreas 2009;10(4):357-60.
2009: Hoimes Christopher J; Moyer Matthew T; Saif Muhammad Wasif
Biomarkers for early detection and screening in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
JOP : Journal of the pancreas 2009;10(4):352-6.
2009: Gaudette Renee; Yarcusko John; Saif Muhammad Wasif
The use of real-time online updates for physicians.
JOP : Journal of the pancreas 2009;10(4):351.
2009: Li Jia; Ko Christine J; Saif Muhammad Wasif
Recurrent cutaneous toxic erythema induced by gemcitabine in a patient with pancreatic cancer.
Cutaneous and ocular toxicology 2009;28(3):144-8.
2009: Waris Waris; Naik Seeta; Idrees Imran; Taha Hesham; Camosino Linda; Mehrishi Anshu; Saif Muhammad Wasif
Severe cutaneous reaction to cetuximab with possible association with the use of over-the-counter skin care products in a patient with oropharyngeal cancer.
Cutaneous and ocular toxicology 2009;28(1):41-4.
2009: Li Jia; Peccerillo Jennifer; Kaley Kristin; Saif Muhammad Wasif
Staphylococcus aureus bacteremia related with erlotinib skin toxicity in a patient with pancreatic cancer.
JOP : Journal of the pancreas 2009;10(3):338-40.
2009: Shahrokni Armin; Rajebi Mohammad Reza; Harold Laurie; Saif Muhammad Wasif
Cardiotoxicity of 5-fluorouracil and capecitabine in a pancreatic cancer patient with a novel mutation in the dihydropyrimidine dehydrogenase gene.
JOP : Journal of the pancreas 2009;10(2):215-20.
2009: Smith Alla; Kressley Andrew; Saif Muhammad Wasif
Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
JOP : Journal of the pancreas 2009;10(2):212-4.
2009: Hoimes Christopher J; Strimpakos Alexios S; Saif Muhammad Wasif
Therapeutic tools in pancreatic cancer.
JOP : Journal of the pancreas 2009;10(2):118-22.
2009: Li Jia; Saif Muhammad Wasif
Advancements in the management of pancreatic cancer.
JOP : Journal of the pancreas 2009;10(2):109-17.
2009: Lee Michael Xiang; Saif Muhammad Wasif
Screening for early pancreatic ductal adenocarcinoma: an urgent call!
JOP : Journal of the pancreas 2009;10(2):104-8.
2009: Strimpakos Alexios S; Hoimes Christopher; Saif Muhammad Wasif
Pancreatic cancer: translating lessons from mouse models.
JOP : Journal of the pancreas 2009;10(2):98-103.
2009: Sohail Muhammad Adnan; Saif Muhammad Wasif
Role of anticoagulation in the management of pancreatic cancer.
JOP : Journal of the pancreas 2009;10(2):82-7.
2009: Makrilia Nektaria; Indeck Bonnie; Syrigos Kostas; Saif Muhammad Wasif
Depression and pancreatic cancer: a poorly understood link.
JOP : Journal of the pancreas 2009;10(1):69-76.
2008: Ghetie Cristian; Davies Marianne; Cornfeld Daniel; Suh Namsoo; Saif Muhammad Wasif
Expectoration of a lung metastasis in a patient with colorectal carcinoma.
Clinical colorectal cancer 2008;7(4):283-6.
2008: Nishihori Taiga; Strazzabosco Mario; Saif Muhammad Wasif
Incidence and management of colorectal cancer in liver transplant recipients.
Clinical colorectal cancer 2008;7(4):260-6.
2008: Saif Muhammad Wasif; Cornfeld Daniel; Modarresifar Houmayoun; Ojha Buddhiwardhan
18F-FDG positron emission tomography CT (FDG PET-CT) in the management of pancreatic cancer: initial experience in 12 patients.
Journal of gastrointestinal and liver diseases : JGLD 2008;17(2):173-8.
2008: Saif M Wasif
Erlotinib: the first biologic in the management of pancreatic cancer.
Expert opinion on pharmacotherapy 2008;9(9):1595-607.
2008: Saif Muhammad Wasif; Katirtzoglou Nikos A; Syrigos Kostas N
Capecitabine: an overview of the side effects and their management.
Anti-cancer drugs 2008;19(5):447-64.
2008: Syrigos K N; Zalonis A; Kotteas E; Saif Muhammad Wasif
Targeted therapy for oesophageal cancer: an overview.
Cancer metastasis reviews 2008;27(2):273-88.
2008: Saif Muhammad Wasif
Management of hypomagnesemia in cancer patients receiving chemotherapy.
The journal of supportive oncology 2008;6(5):243-8.
2008: Saif M Wasif; Longo Walter L; Israel Gary
Correlation between rash and a positive drug response associated with bevacizumab in a patient with advanced colorectal cancer.
Clinical colorectal cancer 2008;7(2):144-8.
2008: Saif Muhammad Wasif
Erlotinib-induced acute hepatitis in a patient with pancreatic cancer.
Clinical advances in hematology & oncology : H&O 2008;6(3):191-199.
2008: Syrigou Ekaterini; Syrigos Kostas; Saif M Wasif
Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.
Current allergy and asthma reports 2008;8(1):56-62.
2008: Saif Muhammad Wasif; Hashmi Shahrukh
Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer.
Cancer chemotherapy and pharmacology 2008;61(3):349-54.
2008: Saif M W; Hashmi Shahrukh; Zelterman Daniel; Almhanna Khaldoun; Kim Richard
Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review.
International journal of colorectal disease 2008;23(2):139-45.
2008: Saif Muhammad Wasif; Tomita Megumi; Ledbetter Leslie; Diasio Robert B
Capecitabine-related cardiotoxicity: recognition and management.
The journal of supportive oncology 2008;6(1):41-8.
2008: Saif Muhammad Wasif; Sandoval Amanda
Atypical hand-and-foot syndrome in an African American patient treated with capecitabine with normal DPD activity: is there an ethnic disparity?
Cutaneous and ocular toxicology 2008;27(4):311-5.
2008: Saif Muhammad Wasif
Hepatic failure and hepatorenal syndrome secondary to erlotinib. Safety reminder.
JOP : Journal of the pancreas 2008;9(6):748-52.
2008: Saif Muhammad Wasif; Ramos Jorge; Knisely Jonathan
Radiation recall phenomenon secondary to bevacizumab in a patient with pancreatic cancer.
JOP : Journal of the pancreas 2008;9(6):744-7.
2008: Saif Muhammad Wasif; Wasif Nawal
Interaction between capecitabine and gemcitabine with warfarin in a patient with pancreatic cancer.
JOP : Journal of the pancreas 2008;9(6):739-43.
2008: Shaib Walid; Lansigan Frederick; Cornfeld Daniel; Syrigos Kostas; Saif Muhammad Wasif
Gemcitabine-induced pulmonary toxicity during adjuvant therapy in a patient with pancreatic cancer.
JOP : Journal of the pancreas 2008;9(6):708-14.
2008: Saif Muhammad Wasif
Does OPTIMOX strategy ("stop-and-go" approach) also work in treatment of pancreatic cancer with oxaliplatin-based regimens?
JOP : Journal of the pancreas 2008;9(5):658-63.
2008: Saif Muhammad Wasif
Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008.
JOP : Journal of the pancreas 2008;9(4):403-7.
2008: Saif Muhammad Wasif
Translational research in pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008.
JOP : Journal of the pancreas 2008;9(4):398-402.
2008: Saif Muhammad Wasif
New developments in the treatment of pancreatic cancer. Highlights from the "44th ASCO Annual Meeting". Chicago, IL, USA. May 30 - June 3, 2008.
JOP : Journal of the pancreas 2008;9(4):391-7.
2008: Saadati Hamid; Saif Muhammad Wasif
Capecitabine as salvage therapy for a pancreatic cancer patient with extensive liver metastases and associated impairment of liver function.
JOP : Journal of the pancreas 2008;9(3):354-6.
2008: Saif Muhammad Wasif; Merikas Irene; Tsimboukis Sotirios; Syrigos Kostas
Erlotinib-induced skin rash. Pathogenesis, clinical significance and management in pancreatic cancer patients.
JOP : Journal of the pancreas 2008;9(3):267-74.
2008: Kang Soonmo Peter; Saif Muhammad Wasif
Pharmacogenomics and pancreatic cancer treatment. Optimizing current therapy and individualizing future therapy.
JOP : Journal of the pancreas 2008;9(3):251-66.
2008: Saif Muhammad Wasif; Seller Sandra; Diasio Robert B
Atypical toxicity associated with 5-Fluororacil in a DPD-deficient patient with pancreatic cancer. Is ethnicity a risk factor?
JOP : Journal of the pancreas 2008;9(2):226-9.
2008: Shahrokni Armin; Matuszczak Justyna; Rajebi Mohammad Reza; Saif Muhammad Wasif
Erlotinib-induced episcleritis in a patient with pancreatic cancer.
JOP : Journal of the pancreas 2008;9(2):216-9.
2008: Elligers Kyle T; Davies Marianne; Sanchis Desiree; Ferencz Thomas; Saif Muhammad Wasif
Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?
JOP : Journal of the pancreas 2008;9(2):197-202.
2008: Alsamarai Susan; Zergebel Chris; Zhang Joshua; Furuie Taro; Urrea Peter D; Saif Muhammad Wasif
Long term survival on S-1 monotherapy in a patient with recurrent stage IV pancreatic cancer.
JOP : Journal of the pancreas 2008;9(2):185-91.
2008: Saif Muhammad Wasif
Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 25-27, 2008.
JOP : Journal of the pancreas 2008;9(2):91-8.
2008: Kang Soonmo Peter; Saif Muhammad Wasif
Optimal second line treatment options for gemcitabine refractory advanced pancreatic cancer patients. Can we establish standard of care with available data?
JOP : Journal of the pancreas 2008;9(2):83-90.
2007: Steg Adam; Vickers Selwyn M; Eloubeidi Mohamad; Wang Wenquan; Eltoum Isam A; Grizzle William E; Saif M Wasif; Lobuglio Al F; Frost Andra R; Johnson Martin R
Hedgehog pathway expression in heterogeneous pancreatic adenocarcinoma: implications for the molecular analysis of clinically available biopsies.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2007;16(4):229-37.
2007: Saif Muhammad Wasif; Kim Richard
Role of platinum agents in the management of advanced pancreatic cancer.
Expert opinion on pharmacotherapy 2007;8(16):2719-27.
2007: Saif Muhammad Wasif; Sellers Sandra; Li Mao; Wang Wei; Cusimano Linda; Wang Hui; Zhang Ruiwen
A phase I study of bi-weekly administration of 24-h gemcitabine followed by 24-h irinotecan in patients with solid tumors.
Cancer chemotherapy and pharmacology 2007;60(6):871-82.
2007: Kang Soonmo Peter; Saif Muhammad Wasif
Infusion-related and hypersensitivity reactions of monoclonal antibodies used to treat colorectal cancer--identification, prevention, and management.
The journal of supportive oncology 2007;5(9):451-7.
2007: Saif M Wasif; Roy Shailja; Ledbetter Leslie; Madison Jennifer; Syrigos Kostas
Fever as the only manifestation of hypersensitivity reactions associated with oxaliplatin in a patient with colorectal cancer Oxaliplatin-induced hypersensitivity reaction.
World journal of gastroenterology : WJG 2007;13(39):5277-81.
2007: Saif Muhammad Wasif; Juneja Vinni; Black Glenda; Thronton Jennifer; Johnson Martin R; Diasio Robert B
Palmar-plantar erythrodysesthesia in patients receiving capecitabine and intratumor thymidine phosphorylase and dihydropyrimidine dehydrogenase: is there a pharmacologic explanation?
Supportive cancer therapy 2007;4(4):211-8.
2007: Saif Muhammad Wasif; Tejani Mohamedtaki A
Safety of capecitabine use in patients with liver dysfunction.
Clinical advances in hematology & oncology : H&O 2007;5(9):730-2; discussion 736.
2007: Saif M-Wasif; Khubchandani Sapna; Walczak Marek
Secondary pancreatic involvement by a diffuse large B-cell lymphoma presenting as acute pancreatitis.
World journal of gastroenterology : WJG 2007;13(36):4909-11.
2007: Saif Muhammad Wasif; Karapanagiotou Lena; Syrigos Kostas
Genetic alterations in pancreatic cancer.
World journal of gastroenterology : WJG 2007;13(33):4423-30.
2007: Saif Muhammad Wasif; Berk Greg; Cheng Yung-Chi; Kinsella Timothy James
IPdR: a novel oral radiosensitizer.
Expert opinion on investigational drugs 2007;16(9):1415-24.
2007: Saif M W; Ezzeldin Hany; Vance Katisha; Sellers Sandra; Diasio Robert B
DPYD*2A mutation: the most common mutation associated with DPD deficiency.
Cancer chemotherapy and pharmacology 2007;60(4):503-7.
2007: Saif Muhammad Wasif; Black Glenda; Roy Shalija; Bell Diana; Russo Suzanne; Eloubeidi Mohamed A; Steg Adam; Johnson Martin R; Zelterman Daniel; Diasio Robert B
Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
Cancer journal (Sudbury, Mass.) 2007;13(4):247-56.
2007: Wrzesinski Stephen H; McGurk Meghan L; Donovan Constance T; Ferencz Thomas M; Saif Muhammad Wasif
Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfate.
Anti-cancer drugs 2007;18(6):721-4.
2007: Saif Muhammad Wasif; Elfiky Aymen A
Identifying and treating fluoropyrimidine-associated hand-and-foot syndrome in white and non-white patients.
The journal of supportive oncology 2007;5(7):337-43.
2007: Elfiky Aymen A; Saif Muhammad W
The developing trend of monoclonal antibodies in the treatment of colorectal cancer.
Expert opinion on biological therapy 2007;7(6):871-83.
2007: Saif Muhammad Wasif; Elfiky Aymen; Salem Ronald R
Gastrointestinal perforation due to bevacizumab in colorectal cancer.
Annals of surgical oncology 2007;14(6):1860-9.
2007: Saif Muhammad Wasif; Zalonis Antonis; Syrigos Kostas
The clinical significance of autoantibodies in gastrointestinal malignancies: an overview.
Expert opinion on biological therapy 2007;7(4):493-507.
2007: Saif Muhammad Wasif; Fekrazad Mohammad Houman; Ledbetter Leslie; Diasio Robert B
Hypokalemia secondary to capecitabine: a hidden toxicity?
Therapeutics and clinical risk management 2007;3(1):177-80.
2007: Saif M Wasif; Kim Richard
Incidence and management of cutaneous toxicities associated with cetuximab.
Expert opinion on drug safety 2007;6(2):175-82.
2007: Cohenuram Michael; Saif Muhammad Wasif
Panitumumab the first fully human monoclonal antibody: from the bench to the clinic.
Anti-cancer drugs 2007;18(1):7-15.
2007: Saif Muhammad Wasif; Kang Soonmo Peter; Ledbetter Leslie; Steg Adam; Diasio Robert; Johnson Martin
Long-term survival on capecitabine in two gemcitabine refractory pancreatic cancer patients. Is there a pharmacogenetic explanation?
JOP : Journal of the pancreas 2007;8(6):799-805.
2007: Antoine Monique; Khitrik-Palchuk Marina; Saif Muhammad Wasif
Long-term survival in a patient with acinar cell carcinoma of pancreas. A case report and review of literature.
JOP : Journal of the pancreas 2007;8(6):783-9.
2007: Saif Muhammad Wasif
Controversies in the adjuvant treatment of pancreatic adenocarcinoma.
JOP : Journal of the pancreas 2007;8(5):545-52.
2007: Saif Muhammad Wasif; Shahrokni Armin; Cornfeld Daniel
Gemcitabine-induced liver fibrosis in a patient with pancreatic cancer.
JOP : Journal of the pancreas 2007;8(4):460-7.
2007: Saif Muhammad Wasif
Pancreatic cancer: is this bleak landscape finally changing? Highlights from the '43rd ASCO Annual Meeting'. Chicago, IL, USA. June 1-5, 2007.
JOP : Journal of the pancreas 2007;8(4):365-73.
2007: Kim Richard; Saif Muhammad Wasif
Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer?
JOP : Journal of the pancreas 2007;8(3):279-88.
2007: Fazal Salman; Saif Muhammad Wasif
Supportive and palliative care of pancreatic cancer.
JOP : Journal of the pancreas 2007;8(2):240-53.
2007: Saif Muhammad Wasif
Pancreatic cancer: are we moving forward yet? Highlights from the Gastrointestinal Cancers Symposium. Orlando, FL, USA. January 20th, 2007.
JOP : Journal of the pancreas 2007;8(2):166-76.
2007: Saif Muhammad Wasif
Pancreatoblastoma.
JOP : Journal of the pancreas 2007;8(1):55-63.
2007: Cohenuram Michael; Saif Muhammad Wasif
Epidermal growth factor receptor inhibition strategies in pancreatic cancer: past, present and the future.
JOP : Journal of the pancreas 2007;8(1):4-15.
2006: Ahluwalia M; Gotlieb V; Damerla V; Saif M Wasif
Aggressive Burkitt-like lymphoma of colon in a patient with prior celiac disease.
The Yale journal of biology and medicine 2006;79(3-4):173-5.
2006: Karapanagiotou Elena; Saif Muhammad Wasif; Rondoyianni Dimitra; Markaki Sofia; Alamara Christina; Kiagia Maria; Pantazopoulos Kosmas; Tzannou Ifigenia; Syrigos Kostas
Metastatic cervical carcinoma to the thyroid gland: a case report and review of the literature.
The Yale journal of biology and medicine 2006;79(3-4):165-8.
2006: Saif Muhammad Wasif; Kang S Peter; Chu Edward
Treatment of metastatic colorectal cancer: from cytotoxic agents to molecular agents and multitargeted strategies.
Oncology (Williston Park, N.Y.) 2006;20(14 Suppl 10):11-9.
2006: Patel Shreyaskumar; Keohan Mary Louise; Saif M Wasif; Rushing Daniel; Baez Luis; Feit Kevie; DeJager Robert; Anderson Sibyl
Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy.
Cancer 2006;107(12):2881-7.
2006: Saif Muhammad Wasif; Black Glenda; Johnson Martin; Russo Suzanne; Diasio Robert
Radiation recall phenomenon secondary to capecitabine: possible role of thymidine phosphorylase.
Cancer chemotherapy and pharmacology 2006;58(6):771-5.
2006: Gotlib Vladimir; Khaled Samer; Lapko Igor; Mar Nataliya; Saif Muhammad Wasif
Skin rash secondary to bevacizumab in a patient with advanced colorectal cancer and relation to response.
Anti-cancer drugs 2006;17(10):1227-9.
2006: Saif Muhammad Wasif; Hashmi Shahrukh; Mattison Lori; Donovan William B; Diasio Robert B
Peripheral neuropathy exacerbation associated with topical 5-fluorouracil.
Anti-cancer drugs 2006;17(9):1095-8.
2006: Saif Muhammad Wasif; Merritt James; Robbins Joan; Stewart Jeffrey; Schupp Joachim
Phase III multicenter randomized clinical trial to evaluate the safety and efficacy of CoFactor/5-fluorouracil/bevacizumab versus leucovorin/5-fluorouracil/bevacizumab as initial treatment for metastatic colorectal carcinoma.
Clinical colorectal cancer 2006;6(3):229-34.
2006: Saif Muhammad Wasif; Elfiky Aymen; Diasio Robert
Hand-foot syndrome variant in a dihydropyrimidine dehydrogenase-deficient patient treated with capecitabine.
Clinical colorectal cancer 2006;6(3):219-23.
2006: Mattison Lori Kay; Fourie Jeanne; Desmond Renee A; Modak Anil; Saif Muhammad Wasif; Diasio Robert B
Increased prevalence of dihydropyrimidine dehydrogenase deficiency in African-Americans compared with Caucasians.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5491-5.
2006: Saif M Wasif
Hypersensitivity reactions associated with oxaliplatin.
Expert opinion on drug safety 2006;5(5):687-94.
2006: Saif Muhammad Wasif; Mattison Lori; Carollo Tom; Ezzeldin Hany; Diasio Robert B
Dihydropyrimidine dehydrogenase deficiency in an Indian population.
Cancer chemotherapy and pharmacology 2006;58(3):396-401.
2006: Saif Mohammad Wasif; Cohenuram Michael
Role of panitumumab in the management of metastatic colorectal cancer.
Clinical colorectal cancer 2006;6(2):118-24.
2006: Saif M Wasif; Mehra Ranee
Incidence and management of bevacizumab-related toxicities in colorectal cancer.
Expert opinion on drug safety 2006;5(4):553-66.
2006: Saif Muhammad Wasif; von Borstel Reid
5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
Cancer chemotherapy and pharmacology 2006;58(1):136-42.
2006: Saif Mohammad Wasif
Targeted agents for adjuvant therapy of colon cancer.
Clinical colorectal cancer 2006;6(1):46-51.
2006: Cortez-Escalante Juan José; Castro Cleudson; Romero Gustavo Adolfo Sierra; Matos Luiza; Saif Muhammad Wasif
Pulmonary thromboembolism in AIDS patient with chronic venous insufficiency, pulmonary tuberculosis and breast cancer: a case report and pathophysiology review.
Revista do Instituto de Medicina Tropical de São Paulo 2006;48(2):105-8.
2006: Curtis Brian R; Kaliszewski James; Marques Marisa B; Saif M Wasif; Nabelle Lisle; Blank Jules; McFarland Janice G; Aster Richard H
Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
American journal of hematology 2006;81(3):193-8.
2006: Saif M Wasif; Diasio Robert
Is capecitabine safe in patients with gastrointestinal cancer and dihydropyrimidine dehydrogenase deficiency?
Clinical colorectal cancer 2006;5(5):359-62.
2006: Shah Heather R; Ledbetter Leslie; Diasio Robert; Saif M Wasif
A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin.
Clinical colorectal cancer 2006;5(5):354-8.
2006: Saif M Wasif; Sellers Sandra; Russo Suzanne
Gemcitabine-related radiation recall in a patient with pancreatic cancer.
Anti-cancer drugs 2006;17(1):107-11.
2006: Saif Muhammad Wasif
Pancreatic cancer: highlights from the 42nd annual meeting of the American Society of Clinical Oncology, 2006.
JOP : Journal of the pancreas 2006;7(4):337-48.
2006: Saif Muhammad Wasif
Primary pancreatic lymphomas.
JOP : Journal of the pancreas 2006;7(3):262-73.
2006: Saif Muhammad Wasif
Anti-angiogenesis therapy in pancreatic carcinoma.
JOP : Journal of the pancreas 2006;7(2):163-73.
2005: Saif M Wasif; Reardon John
Management of oxaliplatin-induced peripheral neuropathy.
Therapeutics and clinical risk management 2005;1(4):249-58.
2005: Blanquicett Carmelo; Saif M Wasif; Buchsbaum Donald J; Eloubeidi Mohamad; Vickers Selwyn M; Chhieng David C; Carpenter Mark D; Sellers Jeffrey C; Russo Suzanne; Diasio Robert B; Johnson Martin R
Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8773-81.
2005: Saif M Wasif; Eloubeidi Mohammaed A; Russo Suzanne; Steg Adam; Thornton Jennifer; Fiveash John; Carpenter Mark; Blanquicett Carmello; Diasio Robert B; Johnson Martin R
Phase I study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: expression analysis of genes related to outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8679-87.
2005: Saif M Wasif
Management of colorectal cancer in pregnancy: a multimodality approach.
Clinical colorectal cancer 2005;5(4):247-56.
2005: Saif Muhammad Wasif; Zujewski J; Hamilton Michael
Myasthenia gravis in a patient with breast cancer.
The breast journal 2005;11(6):529-30.
2005: Posey James A; Saif M Wasif; Carlisle Ronda; Goetz Andrew; Rizzo Jinee; Stevenson Suzanne; Rudoltz Marc S; Kwiatek Joseph; Simmons Paul; Rowinsky Eric K; Takimoto Chris H; Tolcher Anthony W
Phase 1 study of weekly polyethylene glycol-camptothecin in patients with advanced solid tumors and lymphomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7866-71.
2005: Ayyub Muhammad; Khan M Naeem; Anwar Masood; Waqar Amin; Ali Waqar; Hussain Tassawar; Luqman Muhammad; Sultana Nadira; Karamat Karamat Ahmed; Saif M Wasif
Clinicopathological features of lupus anticoagulant; experience at AFIP during last seven years.
Medical science monitor : international medical journal of experimental and clinical research 2005;11(11):CR536-9.
2005: Saif M Wasif
An adverse interaction between warfarin and fluoropyrimidines revisited.
Clinical colorectal cancer 2005;5(3):175-80.
2005: Saif M Wasif
Capecitabine versus continuous-infusion 5-fluorouracil for colorectal cancer: a retrospective efficacy and safety comparison.
Clinical colorectal cancer 2005;5(2):89-100.
2005: Minter Alex; Malik Rohit; Ledbetter Leslie; Winokur Thomas S; Hawn Mary T; Saif M Wasif
Colon cancer in pregnancy.
Cancer control : journal of the Moffitt Cancer Center 2005;12(3):196-202.
2005: Engstrom Paul F; Benson Al B; Chen Yi-Jen; Choti Michael A; Dilawari Raza A; Enke Charles A; Fakih Marwan G; Fuchs Charles; Kiel Krystyna; Knol James A; Leong Lucille A; Ludwig Kirk A; Martin Edward W; Rao Sujata; Saif M Wasif; Saltz Leonard; Skibber John M; Venook Alan P; Yeatman Timothy J;
Anal canal cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):510-5.
2005: Engstrom Paul F; Benson Al B; Chen Yi-Jen; Choti Michael A; Dilawari Raza A; Enke Charles A; Fakih Marwan G; Fuchs Charles; Kiel Krystyna; Knol James A; Leong Lucille A; Ludwig Kirk A; Martin Edward W; Rao Sujata; Saif M Wasif; Saltz Leonard; Skibber John M; Venook Alan P; Yeatman Timothy J;
Rectal cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):492-508.
2005: Engstrom Paul F; Benson Al B; Chen Yi-Jen; Choti Michael A; Dilawari Raza A; Enke Charles A; Fakih Marwan G; Fuchs Charles; Kiel Krystyna; Knol James A; Leong Lucille A; Ludwig Kirk A; Martin Edward W; Rao Sujata; Saif M Wasif; Saltz Leonard; Skibber John M; Venook Alan P; Yeatman Timothy J;
Colon cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):468-91.
2005: Saif Muhammad Wasif; McGee Philip J
Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.
JOP : Journal of the pancreas 2005;6(4):369-74.
2005: Saif Muhammad Wasif; Moody John S; Russo Suzanne M
Gastrointestinal bleeding associated with concurrent capecitabine and radiotherapy in patients with pancreatic cancer.
JOP : Journal of the pancreas 2005;6(4):325-33.
2005: Wright Maurice A; Morrison Geraldine; Lin Pengxin; Leonard Gregory D; Nguyen Dat; Guo Xaiodu; Szabo Eva; Hopkins Jon L; Leguizamo Jorge P; Harold Nancy; Fioravanti Suzanne; Schuler Barbara; Monahan Brian P; Saif M Wasif; Quinn Mary G; Pang Janet; Grem Jean L
A phase I pharmacologic and pharmacogenetic trial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4144-50.
2005: Saif M Wasif; Diasio Robert B
Edotecarin: a novel topoisomerase I inhibitor.
Clinical colorectal cancer 2005;5(1):27-36.
2005: Saif Muhammad Wasif; Sviglin Helena; Carpenter Mark
Impact of ethnicity on outcome in pancreatic carcinoma.
JOP : Journal of the pancreas 2005;6(3):246-54.
2004: Saif M Wasif; Wood Tina E; McGee Philip J; Diasio Robert B
Peripheral neuropathy associated with capecitabine.
Anti-cancer drugs 2004;15(8):767-71.
2003: Guo Xiao-Du; Harold Nancy; Saif M Wasif; Schuler Barbara; Szabo Eva; Hamilton J Michael; Monahan Brian P; Quinn Mary G; Cliatt Janet; Nguyen Diana; Grollman Frank; Thomas Rebecca R; McQuigan Elizabeth A; Wilson Richard; Takimoto Chis H; Grem Jean L
Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule.
Cancer chemotherapy and pharmacology 2003;52(1):79-85.
2003: Saif Muhammad Wasif; Takimoto Chris H
Pineal germinoma followed by hematogenous metastases.
Southern medical journal 2003;96(1):117-9.
2003: Saif Muhammad Wasif
Is there a role for thiamine in the management of congestive heart failure?
Southern medical journal 2003;96(1):114-5.
2003: Saif M Wasif; Quinn Mary G; Thomas Rebecca R; Ernst Aaron; Grem Jean L
Cardiac toxicity associated with capecitabine therapy.
Acta oncologica (Stockholm, Sweden) 2003;42(4):342-4.
2002: Saif Muhammad Wasif; Hopkins Jon L; Gore Steven D
Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Leukemia & lymphoma 2002;43(11):2083-92.
2001: Saif M W; Hamilton J M
A 25 year old woman presenting with bleeding disorder and nystagmus.
Postgraduate medical journal 2001;77(912):E6.
2001: Saif M W; Wilson R H; Harold N; Keith B; Dougherty D S; Grem J L
Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracil.
Anti-cancer drugs 2001;12(6):525-31.
2001: Saif M W; Little R F; Hamilton J M; Allegra C J; Wilson W H
Reactivation of chronic hepatitis B infection following intensive chemotherapy and successful treatment with lamivudine: a case report and review of the literature.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(1):123-9.
2000: Saif M W; Hamilton J M; Allegra C J
Varicella zoster meningitis preceeded by thrombophlebitis in a patient with Hodgkin's disease.
Leukemia & lymphoma 2000;39(3-4):421-6.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Muhammad Wasif Saif

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Muhammad Wasif Saif (preview)

All Publications